133 related articles for article (PubMed ID: 16511777)
1. (1-->3) beta -D-glucan assay in the diagnosis of invasive fungal infections.
Upton A; Leisenring W; Marr KA
Clin Infect Dis; 2006 Apr; 42(7):1054-6; author reply 1056. PubMed ID: 16511777
[No Abstract] [Full Text] [Related]
2. Reappraisal of the serum (1-->3)-beta-D-glucan assay for the diagnosis of invasive fungal infections--a study based on autopsy cases from 6 years.
Obayashi T; Negishi K; Suzuki T; Funata N
Clin Infect Dis; 2008 Jun; 46(12):1864-70. PubMed ID: 18462174
[TBL] [Abstract][Full Text] [Related]
3. [Problems and recent advances in measurement of (1-->3)-beta-D-glucan].
Yoshida K; Shoji H; Niki Y
Nihon Ishinkin Gakkai Zasshi; 2008; 49(2):75-80. PubMed ID: 18451587
[TBL] [Abstract][Full Text] [Related]
4. Invasive fungal infections and (1,3)-beta-D-glucan serum concentrations in long-term intensive care patients.
Presterl E; Parschalk B; Bauer E; Lassnigg A; Hajdu S; Graninger W
Int J Infect Dis; 2009 Nov; 13(6):707-12. PubMed ID: 19157947
[TBL] [Abstract][Full Text] [Related]
5. [1,3-Beta-D-glucan measurement and its usefulness in the diagnosis of invasive fungal infections].
Kocmanová I; Rácil Z; Koukalová D; Mayer J
Klin Mikrobiol Infekc Lek; 2008 Jun; 14(3):88-92. PubMed ID: 18688768
[TBL] [Abstract][Full Text] [Related]
6. [Utility of galactomannan enzyme immunoassay and (1,3)beta-D-glucan assay in invasive fungal infection].
Yu J; Li RY; Gao LJ; Lu QY; Wang XH
Zhonghua Yi Xue Za Zhi; 2010 Feb; 90(6):371-4. PubMed ID: 20367931
[TBL] [Abstract][Full Text] [Related]
7. [The diagnostic value of detecting plasma 1, 3-beta-D-glucan for invasive fungal infections].
Lü PH; Zhao BL; Shi Y; Wen YT
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jan; 30(1):31-4. PubMed ID: 17326970
[TBL] [Abstract][Full Text] [Related]
8. [Detection of 1,3-beta-D glucan for diagnosis of invasive fungal infections in hematooncological patients: usefulness for screening of invasive mycosis and for confirmation of galactomannan positive results].
Rácil Z; Kocmanová I; Weinbergerová B; Winterová J; Lengerová M; Hrncírová K; Mayer J
Klin Mikrobiol Infekc Lek; 2009 Apr; 15(2):48-57. PubMed ID: 19488961
[TBL] [Abstract][Full Text] [Related]
9. Comparable Serum and Plasma 1,3-β-d-Glucan Values Obtained Using the Wako β-Glucan Test in Patients with Probable or Proven Fungal Diseases.
De Carolis E; Marchionni F; Torelli R; Posteraro P; De Pascale G; Carelli S; Sanguinetti M; Posteraro B
J Clin Microbiol; 2019 May; 57(5):. PubMed ID: 30842228
[No Abstract] [Full Text] [Related]
10. A novel enzyme immunoassay for the measurement of plasma (1 → 3)-β-D-glucan levels.
Sunamura EI; Iwasaki M; Shiina S; Kitahara SI; Yotani T; Manabe M; Miyazaki O
J Immunol Methods; 2020 Dec; 487():112872. PubMed ID: 33007318
[TBL] [Abstract][Full Text] [Related]
11. Serum (1->3)-β-D-glucan measurement in coccidioidomycosis.
Thompson GR; Bays DJ; Johnson SM; Cohen SH; Pappagianis D; Finkelman MA
J Clin Microbiol; 2012 Sep; 50(9):3060-2. PubMed ID: 22692738
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of (1 → 3)-β-D-glucan in bronchoalveolar lavage fluid for invasive fungal disease: A meta-analysis.
Shi XY; Liu Y; Gu XM; Hao SY; Wang YH; Yan D; Jiang SJ
Respir Med; 2016 Aug; 117():48-53. PubMed ID: 27492513
[TBL] [Abstract][Full Text] [Related]
13. Clinical viability of Fungitell, a new (1→3)-β-D: -glucan measurement kit, for diagnosis of invasive fungal infection, and comparison with other kits available in Japan.
Yoshida K; Shoji H; Takuma T; Niki Y
J Infect Chemother; 2011 Aug; 17(4):473-7. PubMed ID: 21210174
[TBL] [Abstract][Full Text] [Related]
14. Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans.
Ostrosky-Zeichner L; Alexander BD; Kett DH; Vazquez J; Pappas PG; Saeki F; Ketchum PA; Wingard J; Schiff R; Tamura H; Finkelman MA; Rex JH
Clin Infect Dis; 2005 Sep; 41(5):654-9. PubMed ID: 16080087
[TBL] [Abstract][Full Text] [Related]
15. 1,3-Beta-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia.
Senn L; Robinson JO; Schmidt S; Knaup M; Asahi N; Satomura S; Matsuura S; Duvoisin B; Bille J; Calandra T; Marchetti O
Clin Infect Dis; 2008 Mar; 46(6):878-85. PubMed ID: 18260755
[TBL] [Abstract][Full Text] [Related]
16. [Investigation of the cutoff value of a serum 1,3-beta-D-glucan assay for early diagnosis of invasive fungal infection in Chinese hematopoietic stem cell transplant recipients].
Ji Y; Huang XJ
Zhonghua Xue Ye Xue Za Zhi; 2008 Jun; 29(6):405-7. PubMed ID: 19031745
[TBL] [Abstract][Full Text] [Related]
17. Role of serum (1,3)-β-d-glucan assay in early diagnosis of invasive fungal infections in a neonatal intensive care unit.
Shabaan AE; Elbaz LM; El-Emshaty WM; Shouman B
J Pediatr (Rio J); 2018; 94(5):559-565. PubMed ID: 29144965
[TBL] [Abstract][Full Text] [Related]
18. β-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3).
Lamoth F; Cruciani M; Mengoli C; Castagnola E; Lortholary O; Richardson M; Marchetti O;
Clin Infect Dis; 2012 Mar; 54(5):633-43. PubMed ID: 22198786
[TBL] [Abstract][Full Text] [Related]
19. Preemptive treatment of fungal infection based on plasma (1 --> 3)beta-D-glucan levels after liver transplantation.
Akamatsu N; Sugawara Y; Kaneko J; Tamura S; Makuuchi M
Infection; 2007 Oct; 35(5):346-51. PubMed ID: 17885729
[TBL] [Abstract][Full Text] [Related]
20. β-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis.
Karageorgopoulos DE; Vouloumanou EK; Ntziora F; Michalopoulos A; Rafailidis PI; Falagas ME
Clin Infect Dis; 2011 Mar; 52(6):750-70. PubMed ID: 21367728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
